Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 36858723

Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer: final 10-year analysis of the open-label, single-arm, phase 2 APT trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2023 Mar
First author
Tolaney SM

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2023 Mar;24(3):200-201. doi: 10.1016/S1470-2045(23)00064-5.
    note
    Source null
    related pmid
    36858719
    relationship
    Comment in

Authors and identifiers

  1. name
    Tolaney SM
    type
    Author
  2. name
    Tarantino P
    type
    Author
  3. name
    Graham N
    type
    Author
  4. name
    Tayob N
    type
    Author
  5. name
    Parè L
    type
    Author
  6. name
    Villacampa G
    type
    Author
  7. name
    Dang CT
    type
    Author
  8. name
    Yardley DA
    type
    Author
  9. name
    Moy B
    type
    Author
  10. name
    Marcom PK
    type
    Author
  11. name
    Albain KS
    type
    Author
  12. name
    Rugo HS
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Tolaney SM
    type
    Author
  2. name
    Tarantino P
    type
    Author
  3. name
    Graham N
    type
    Author
  4. name
    Tayob N
    type
    Author
  5. name
    Parè L
    type
    Author
  6. name
    Villacampa G
    type
    Author
  7. name
    Dang CT
    type
    Author
  8. name
    Yardley DA
    type
    Author
  9. name
    Moy B
    type
    Author
  10. name
    Marcom PK
    type
    Author
  11. name
    Albain KS
    type
    Author
  12. name
    Rugo HS
    type
    Author
bibliography ids
  1. nci-bib-5912efa546875261a5bcfcde
book metadata
content sha256
02cf751f45f052415219647e43ffaeb6607a267660296d7f8454e02e05bb2a10
document type
citation
dois
  1. 10.1016/S1470-2045(23)00051-7
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:36858723
immutable id
pubmed:36858723@02cf751f45f052415219647e43ffaeb6607a267660296d7f8454e02e05bb2a10
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
3
name
The Lancet. Oncology
nlm unique id
100957246
pages
273-285
volume
24
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2023 Mar;24(3):200-201. doi: 10.1016/S1470-2045(23)00064-5.
    note
    Source null
    related pmid
    36858719
    relationship
    Comment in
outcomes validated
false
pmid
36858723
provenance
batch id
d370e99271168e8a8a13
provider
NCBI PubMed ESummary
record sha256
93fdc7a3d6f196dcf47e5c5135b5705752ca7609c01514a0a9c634d06876e32e
response sha256
f65ace3ceb1efa86f3fbab8e01ce265243e7c6b7f13c5f71c357c1f219ad79c4
retrieved at
2026-09-09T23:48:13.005737+00:00
publication date
display
2023 Mar
precision
month
year
2023
publication types
  1. Clinical Trial, Phase II
  2. Journal Article
  3. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/36858723/
title
Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer: final 10-year analysis of the open-label, single-arm, phase 2 APT trial.

Preserved source evidence · Not medical advice